This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF PULSE PROTOCOL

Medical Travel Platform for Hospitals & Doctors

Pulse's mission is to help create a world where everyone will have access to quality healthcare, transparent pricing, and patient advocacy. Following the disruptive platform business model of companies like Uber and Airbnb, Pulse provides a comprehensive software and marketing platform for doctors and hospitals enabling them to professionally manage their medical travel businesses and generate predictable revenue. This market is projected to reach $207.5 billion by 2027.

Show more

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

$210,855.03 Raised

REASONS TO INVEST

Reasons Icon

Founded by 3 industry leaders: Pulse’s leading executives have a combined 50+ years of experience leading the medical travel industry.

Reasons Icon

Compelling business model: Pulse earns recurring revenue both from (1) licensing its software and (2) providing marketing services. Pulse also charges transaction fees for every (3) booked procedure or (4) lead procured.

Reasons Icon

Backed by Institutional Investors: Amplify, Afore Capital, Kima Ventures, Cherry Tree Investments, Street Edge Capital.

TEAM

Robert Page

Robert Page • CEO & Founder

Robert Page has been at the forefront of global health innovation since 2000. A relentless enthusiast for quality control, transparent pricing, and patient advocacy, he has co-authored 3 industry guidebooks, spoken at dozens of conferences across the planet, and led two different medical tourism companies, MedToGo International and PulseProtocol. A graduate of Amplify LA’s prestigious accelerator program, Pulse (formally named, "MedRepublic") was selected among the top 25 new tech companies of 2016 to pitch at Tech Crunch Disrupt and has received investments from multiple VCs, angels, and family offices. 

Read More

Jonathan Edelheit

Jonathan Edelheit • Growth, Business Development

Jonathan Edelheit is Founder and Chairman of the Medical Tourism Association and Global Healthcare Resources and has led the organizations in global development. 

After Villanova Law School, Mr. Edelheit created one of the first low-cost healthcare plans for employers and was the first person in the United States to implement medical tourism into fully-insured and self-funded employer healthcare plans. 

He has additionally launched medical tourism strategies and helped commercialize governments, hospitals and insurers. Mr. Edelheit and his organization, in partnership with the Korean Government, launched South Korea’s global healthcare initiative, taking it from scratch to being one of the largest players in medical travel. Passionate about breaking down the barriers to care access and pricing and quality transparency, he has worked with governments and healthcare providers to launch initiatives in Dubai, Abu Dhabi, Korea, Croatia. Mr. Edelheit has also helped several large insurance companies adopt medical travel into their insurance plans. Mr. Edelheit has been interviewed by hundreds of media outlets around the world from the Wall Street Journal, to Time Magazine and USA Today. Mr. Edelheit runs some of the most influential groups on Linkedin and has hundreds of thousands of members that participate in his healthcare and insurance groups. Mr. Edelheit’s personal hobbies are hiking, scuba diving, boating, spearfishing, skydiving, and traveling, as well as hanging with his new son, Roman, and showing him the world.

Jonathan splits his time between Pulse and the above organizations. 

Read More

Renée-Marie Stephano

Renée-Marie Stephano • Growth, Business Development (Part-Time)

Renée-Marie Stephano, JD is founder and CEO of Global Healthcare Resources, the leading global consulting and market solutions firm in Medical Tourism, Destination Medicine, Wellness Travel and Corporate Wellness. As former president and co-founder of the Medical Tourism Association® and editor-in-chief of Medical Tourism Magazine®, Renée-Marie is considered an expert in medical travel with a strong background in destination development strategies.

GHR’s outreach spans a network of over 2 million professionals through its managed organizations, events, magazines, books and large social network. She has authored several books “Developing International Patient Centers, Best Practices in Facilitation,” "Medical Tourism for Insurers and Employers,” and “Engaging Wellness ~ Corporate Wellness Programs that Work.”

She is founder of the International Healthcare Research Center, which publishes the peer-reviewed and academically validated Medical Tourism Index® and produced the Arabic Medical Tourism Index in 2016 for Dubai Health Authority.

Renée-Marie is a keynote speaker at international conferences, has spoken at hundreds of events and is a featured source of reference for media outlets around the world.

Renée-Marie currently works part time with Pulse. 

Read More

OUR LEADERSHIP


Run by experts with deep and wide connections throughout the medical travel industry

CEO & Co-Founder Robert Page has published 3 industry books and has 20 years of industry experience building and managing medical travel technology companies, successfully facilitating more than 10,000 international procedures.


Co-Founders Jonathan Edelheit and Renée-Marie Stephano have each had 16 years of experience building the industry’s prominent organizations, including the Medical Tourism Association (MTA) and Global Healthcare Resources.


  • MTA: industry thought leader, the MTA maintains a global audience of over 800,000 industry professionals, hosts the industry’s annual conference, and publishes the industry’s journal.
  • GHR: actively consults with a half dozen major governments all around the world on their medical travel growth strategies and has built multiple countries into successful medical travel destinations, including S. Korea, Puerto Rico, and the UAE. 

We are confident our co-founders’ involvement and influence within these organizations put us in a strategic position to quickly grow the Pulse audience.

Medical Travel could one day save your life - or the lives of your loved ones

In 2014, Pulse founder, Robert Page’s father, a US physician, was diagnosed with cancer and given a grim prognosis. Thanks to his family’s network of connections, years of experience in the medical field, and persistence, they were able to find the care he needed. The best option was to seek medical care outside the United States, which proved to be extremely difficult, even with their vast experience and connections.

The difficulties they encountered along the way, and the lessons they learned, led them to build the Pulse platform, the key to unlocking the full potential of the medical travel industry.


CRM software tailored to the medical travel industry: Pulse technology bridges the gap between medical professionals and patients. 

Its suite of software and marketing solutions allows a doctor or hospital to quickly become relevant in the medical travel industry and customize their spending to generate a predictable level of revenue from patient bookings. 


Patients get access to a network of world-class doctors, transparent pricing, secure engagement, and certified care coordinators. 

With more than 100 medical providers, 11 clinics and 21 hospitals already live on Pulse—as well as founder connections to major industry players within this space — we are confident we have the leadership, partnerships, and business model to completely disrupt and bring medical travel into the mainstream.


In spite of its sizable $100B annual revenues, medical travel is difficult to access and thus continues to be a niche market. Pulse technology will not only make it easier for patients and doctors to connect, but its transparent pricing and high standards will motivate patients to increasingly shop the global market for care that fits their needs. 

The Problem


The medical travel industry is virtually untouched by technology

Based on our research and experience, beyond WhatsApp, email, and spreadsheets, providers lack centralized technology to the field, convert and manage patient prospects outside their domestic markets.

This often leads to missed or mismanaged connections….and when connections do happen, the lack of a cohesive path, formal practices, and intuitive user experience often turn away the more risk-averse patients.

Because of this, the market is vastly underachieving.


*The above information is based on internal research and management's experience.

The Solution


A centralized software that provides scalability, marketing resources, and streamlined patient-provider relationships

As far as we are aware, Pulse is the first technology platform of its kind. We give medical professionals a plug-and-play solution, almost eliminating the learning curve and enabling them to get to market with a minimal investment of time and money. 


Online marketplaces have energized and reshaped many sectors of the economy. Pulse endeavors to build the leading marketplace for global medical travel, providing patients with a safe and secure environment in which to search, engage, and book with world-class providers


Leveraging the power of platform technology, Pulse enables multiple stakeholders in the supply chain to add value to the ecosystem and in return receive commensurate value or compensation. 


Pulse assists providers at any point within the patient management process, whether they’re looking to break into the industry, increase patient volume, or manage existing patient populations.

The Market


More than 23 million patients are seeking medical care internationally

The medical travel industry has grown dramatically over the past decade and is expected to continue expanding at a CAGR of 12.8% over the next several years. The global industry is projected to reach a market size of nearly $273.72 and service 70 million patients by the year 2027.

Source

Our Traction


Each Pulse user adds to and gains value from the existing ecosystem

Hospitals / Dental Clinics

  • 11 clinics live on Pulse

  • 2 clinics run leads through Pulse

  • 21 hospitals live on Pulse

  • 3 hospitals run leads through Pulse

  • 1 stem cell center runs leads through Pulse

Providers

  • 103 providers live on Pulse

  • 2 orthopedic surgeons run leads through Pulse

  • 3 plastic surgeons run leads through Pulse

Patient-Care Coordinators

  • 9 coordinators on Pulse

  • 2 coordinator run leads through Pulse

Marketing Partners

  • 1 marketing partner on Pulse

  • 1 marketing partner runs leads through Pulse


What We Do


With Pulse, your patients get all the support they need to confidently book


In addition to an on-demand team of multi-lingual, trained patient-care coordinators, you and your patients get access to technology solutions specifically built to make the medical tourism process efficient and hassle free.


Network benefits of an existing Pulse provider


When a new patient is introduced into the Pulse ecosystem, they are immediately paired with one of the certified, independent coordinators on our platform. The coordinator assists in obtaining necessary medical information, gauges patient readiness, and acts as a patient advocate.

Only after the patient and coordinator have completed the onboarding process do they connect with a potential provider within the platform. This streamlined process allows providers to dedicate the bulk of their time to patient care, and only engage when absolutely necessary - when a patient is ready for consultation.


The Business Model


We make money when our doctors and patient coordinators make money

Any qualified medical professional or patient-care coordinator can join our platform, reducing the barrier to entry and allowing us to onboard customers quickly.

Procedure Revenue

  • Pulse earns a pre-negotiated transaction fee, which equates to a percentage of the total procedure cost. Current average is $350.
  • Typically, Pulse also charges a $112.50 Trust & Support fee for every transaction.


Lead Generation

  • When Pulse sources a lead, we earn an additional fee. Current average is $350. 



Marketing Subscription 

  • Pulse offers a marketing service for providers to accelerate their patient traction. This involves a one-time setup fee up to $3,000 and a monthly subscription of up to $1,500 per month.


Software Licensing Revenue

  • Fees are negotiated on a case-by-case basis with leading hospital systems, financial institutions, insurance companies, in addition to others.

How We Are Different


A business-to-business solution to strengthen the supply side of medical travel

Before founding Pulse, we had come to realize that doctors & hospitals lack the technology, marketing assets, trained sales team and general understanding of how to succeed in this market.

Our unique B2B solution targets the supply side of this industry, giving them a plug-and-play technology and marketing solution to help them efficiently engage and capture a greater number of patients.

Our Competitors are all B2C Travel Agencies for Medical Travel


…but this model has not generated any winners, because:

*The above information is based on internal research and management's experience.

The Vision


Pulse’s vision is to offer a truly global community of healthcare resources

Just as Uber does not own taxis and Airbnb does not own hotels, Pulse aims to become the largest platform for global healthcare - without owning any hospitals. 


Beyond our niche in the medical travel market, we see how Pulse software can be applied to service other healthcare communities, such as domestic healthcare communities, private insurance, self-insured companies, and government healthcare agencies. 


As Pulse grows, we will increasingly use our influence to promote equitable, transparent, and qualitative healthcare services across the planet.


Beyond our original niche in the medical travel space, we believe the applications of this software are limitless. In addition to vastly expanding the user base on our original platform and streaming connections between international patients and providers, we will serve both the self-funded business and domestic healthcare communities.

Why Invest


You - or your loved ones - might need to search beyond your zip code for life-saving medical care

We believe there are few industries that can generate as impactful a change as the medical travel space. This technology connects patients across the world with innovative and life-saving treatment options that have historically been too difficult for most to access. 

Until this moment, we don’t know of any company that has had the tools, background knowledge, and extensive user research critical to bringing about this healthcare revolution. We have everything in place to make this change—now, all we need is you.



Quick Insert

ABOUT

HEADQUARTERS
1600 Main St
Venice, CA 90291
WEBSITE
View Site
Pulse's mission is to help create a world where everyone will have access to quality healthcare, transparent pricing, and patient advocacy. Following the disruptive platform business model of companies like Uber and Airbnb, Pulse provides a comprehensive software and marketing platform for doctors and hospitals enabling them to professionally manage their medical travel businesses and generate predictable revenue. This market is projected to reach $207.5 billion by 2027.

TERMS

Pulse Protocol
Overview
PRICE PER SHARE
$0.25
DEADLINE
Oct. 9, 2021 at 6:59 AM UTC
VALUATION
$6.16M
FUNDING GOAL
$10K - $1.07M
Breakdown
MIN INVESTMENT
$500
MAX INVESTMENT
$107,000
MIN NUMBER OF SHARES OFFERED
40,000
MAX NUMBER OF SHARES OFFERED
4,279,999
OFFERING TYPE
Equity
SHARES OFFERED
Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.


*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Time-Based Perks

Friends and Family Early Birds

Invest within the first 48 hours and receive additional 20% Bonus Shares.

Super Early Bird Bonus

Invest within the first week and receive additional 15% Bonus Shares.

Early Bird Bonus

Invest within the first two weeks and receive an additional 10% Bonus Shares.

Amount-Based Perks:

Tier 1 | $1,000+

Invest $1,000 and 5% Bonus Shares.

Tier 2 | $2,500+

Invest $2,500 and receive 10% Bonus Shares.

Tier 3| $5,000+

Invest $5,000 and receive 12% Bonus Shares + Marketing Credit (Start Up Package Set Up + 1 months marketing services = $1,300 value).

Tier 4| $10,000+

Invest $10,000 and receive 14% Bonus Shares + Marketing Credit (Growth Package Set Up + 2 months marketing services = $2,900 value).

Tier 5| $15,000+

Invest $15,000 and receive 17% Bonus Shares + Marketing Credit (Growth Package Set Up + 5 months marketing services = $5,450 value).

Tier 6| $30,000+

Invest $30,000 and receive 20% Bonus Shares + Marketing Credit (Pro Package Set Up + 6 months marketing services = $12,000 value).

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Pulse Protocol, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $0.49/ share, you will receive an additional 10 shares of Common Stock meaning you'll own 110 shares for $49. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Administrative Expenses” not strictly for administrative purposes. Any expense labeled “Travel and Entertainment”. Inter company debt or back payments.

ALL UPDATES

10.09.21

Final hours before the Start Engine campaign closes

With only 10 hours to invest, I want to once again thank everyone for their participation. We closed enough with this campaign to launch a few of our key initiatives towards growing our program in 2022 and beyond. The Pulse team is very excited to show you what we can do. Moving forward, you will join us on our journey and receive updates as to our progress. We will make you proud. 

My warm regards,

Robert Page and the Pulse Team

I

10.06.21

3 Days Left & 3 Reasons to Invest in Pulse Protocol

Reasons to Invest
1. Founded by 3 industry leaders: Pulse’s leading executives have a combined 50+ years of experience leading the medical travel industry.
2. Compelling business model: Pulse earns recurring revenue both from (1) licensing its software and (2) providing marketing services. Pulse also charges transaction fees for every (3) booked procedure or (4) lead procured.
3. Backed by Institutional Investors: Amplify, Afore Capital, Kima Ventures, Cherry Tree Investments, Street Edge Capital

10.06.21

Thank you

I'd like to thank EVERYONE of you that has invested in Pulse. Your investment shows that you believe in our team, our platform and especially in our mission to create a world where everyone will have access to quality healthcare, transparent pricing, and patient advocacy.

With regards to upcoming business opportunities, we confidently await this game-changing contract with a fortune 500 company. As always, it's my duty to remind you that there's the chance that we don't land this contract, and that even if we did there is no guarantee you will one day see us on the NY stock exchange.

Feel free to contact us at Pulse: info@pulseprotocol.com

10.04.21

Break Down the Walls between Patients and Doctors

Pulse provides a comprehensive software and marketing platform for doctors and hospitals enabling them to professionally manage their medical travel businesses. And More than 23 million patients are seeking medical care internationally. What happens when we can easily connect them to each other? Join Us to Today in our efforts to Break the barrier between Patients and Doctors! Invest Now in Pulse Protocol. 

10.01.21

7 days left to invest in Pulse Protocol

A quick note on market opportunity ...

More than 23 million patients are seeking medical care internationally
The medical travel industry has grown dramatically over the past decade and is expected to continue expanding at a CAGR of 12.8% over the next several years. The global industry is projected to reach a market size of nearly $273.72 and service 70 million patients by the year 2027
We are ready to service this market and grow to help patients worldwide.
 Invest Now in Pulse Protocol. 



09.28.21

11 Days Left To Invest

The Pulse Protocol Platform is built for collaboration and is easy to use for the entire team as well as the patient. Pulse assists providers at any point within the patient management process, whether they’re looking to break into the industry, increase patient volume, or manage existing patient populations.Are you ready to join us?

09.22.21

New Campaign End Date is 17 days away!

We're excited to announce that we will be moving our end date up to October 8th, 2021.

Pulse continues to grow, this time with a final Q3 of 51% growth over Q2.....and we very soon hope to have a game-changing contract with a Fortune 500 company, that would possibly involve a significant set up fee and on-going monthly revenues. More on this in a later update!

Because of these changes, our lead VC has encouraged us to open a larger round of venture funding at a higher valuation. Of course, things may shift in the coming weeks, and nothing is certain. Look here for further updates.

We want to put all our focus on making Pulse Protocol the best it can be and we would love for you to join us on your journey. Become an investor today if you have not already!

Please note that if you have not been a part of prior closings and you need to cancel your investment, you will have until October 6th, 2021 to do so. Feel free to reach out to Investor Services at contact@startengine.com to assist with this.

09.04.21

September Update

Hello everyone, we've had a busy month onboarding new partners, negotiating new business relationships, and helping international doctors, clinics and hospitals manage their medical travelers.

A Business with Purpose
One of the many medical businesses that are thriving in our program is Trinity Stem Cells. Trinity was founded by a US family that helped their autistic son get stem cell treatments in C. America with remarkable results. They wanted more people to have this outlet, but realized that the prohibitive cost and distance would be insurmountable for many. So, they decided to build a clinic along the US-Mexico border and are now opening multiple clinics in Mexico to provide mesenchymal stem cell treatments to patients with different medical needs with a focus on treating autistic children. They offer costs at about 1/3 of what is offered with competitors, donate treatments to children in Mexico, and allow parents 0% financing options. They authentically believe in what they do and are committed to making this available to as many autistic children as possible. Pulse nurse coordinators booked 4 treatments in the past 24 hours for Trinity following social postings from parents reporting significant improvements in their children following treatments. As you can imagine, helping patients .... and especially the very young ones gives everyone on the Pulse team great purpose and boosts company morale.

In addition to the above we have plenty going on, a lot on the way, and much to celebrate:

  • We're helping open two additional Trinity Stem Cell centers in Mexico this month.
  • We have 5 other business deals in diligence, one of which is an enterprise contract to license a white-labeled version of Pulse.
  • Q3 still has one more month and we have already passed 30% growth over Q2. Q4 hasn't even begun and it has already surpassed Q3 in booked revenues, so we expect it to be BIG.
  • We hired 3 new partners in August - Chief Security Information Officer, Full-Stack Developer, Customer Success Manager.

Thank you all for your support

Robert Page
Pulse CEO

07.02.21

July 2021 Update

I'd like to post a quick update to all of our supporters and followers:

  • Our revenue grew from Q1-2021 to Q2-2021. by 43%
  • We recently requested a disbursement. The funds are being used to hire a senior-level product leader with 20 years of experience.

Please look here for more updates soon. 


06.29.21

Notice of Funds Disbursement

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Pulse Protocol has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Pulse Protocol be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.
Venture Club

Venture Club

Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).

$1,000

Tier 1

Invest $1,000 and 5% Bonus Shares.

$2,500

Tier 2

Invest $2,500 and receive 10% Bonus Shares.

$5,000

Tier 3

Invest $5,000 and receive 12% Bonus Shares + Marketing Credit (Start Up Package Set Up + 1 months marketing services = $1,300 value).

$10,000

Tier 4

Invest $10,000 and receive 14% Bonus Shares + Marketing Credit (Growth Package Set Up + 2 months marketing services = $2,900 value).

$15,000

Tier 5

Invest $15,000 and receive 17% Bonus Shares + Marketing Credit (Growth Package Set Up + 5 months marketing services = $5,450 value).

$30,000

Tier 6

Invest $30,000 and receive 20% Bonus Shares + Marketing Credit (Pro Package Set Up + 6 months marketing services = $12,000 value).

JOIN THE DISCUSSION

0/2500

IB
Ihor Bakhnak

a year ago

2 Years and Zero Updates from the company despite reaching out multiple times.

0

0

MR
Marc Russell

2 years ago

Any update, I haven't been receiving any email updates either.

0

0

JM
Janel McMahon-Rel

3 years ago

I didn't receive an email. Can we get an update on our investment and company progress?

1

0

NY
Nathanael York

3 years ago

No updates on pending deal or progress. I’ve reached out to team via email twice and nothing.

0

0

AB
Andrew Brickson

3 years ago

Any update available or did I miss an email?

3

0

MR
Marc Russell

4 years ago

I recently found this offering and am glad I was able to join before the closing. I had a cousin who needed to find various doctors that weren't local so I have an idea of what Pulse is trying to accomplish. I am glad to see the shortening of the campaign and would agree with what you've accomplished and if some of your pipeline signs that your valuation would dramatically increase and it'd be nice to reflect that in the next offering. How does your pipeline look compared to a year ago? COVID is still around but hopefully not negatively affecting you as it initially did. What is the current roadmap? Is the app ready for full release (I know the software itself will never be "done", but is it good enough to scale?) Is the emphasis in marketing and sales with Hospitals, Clinics, or focusing more with the partnerships and leads?

Show more

1

0

RP
Raj Parajuli

4 years ago

Hello, Is still investor will get Amount-Based Perks?

1

0

JM
Janel McMahon-Rel

4 years ago

Hi how come my funds haven't been invested yet?

2

0

NZ
Noah Zych

4 years ago

Hi, how well does Pulse Protocol interface to other scheduling systems for physicians? Will expected revenue in Pulse Protocol also generate from interfaced orders from other systems?

Show more

1

0

MH
Mohamed Heikal

4 years ago

Hello, How do you manage to over come medico legal and business legal barriers and limitations of health care services across international borders, when these are a big barrier across state borders?!

Show more

1

0

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$210,855.03
INVESTORS
120
MIN INVEST
$500
VALUATION
$6.16M

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.